NASDAQ:ANGO
AngioDynamics Stock News
$5.78
-0.0900 (-1.53%)
At Close: Apr 25, 2024
AngioDynamics (ANGO) Q3 Earnings Lag Estimates, FY23 View Cut
09:24pm, Friday, 31'st Mar 2023
AngioDynamics (ANGO) registers strong revenue growth in the Med Tech and Med Device businesses in third-quarter fiscal 2023.
AngioDynamics (ANGO) Reports Q3 Loss, Lags Revenue Estimates
09:54am, Thursday, 30'th Mar 2023
AngioDynamics (ANGO) delivered earnings and revenue surprises of -200% and 2.28%, respectively, for the quarter ended February 2023. Do the numbers hold clues to what lies ahead for the stock?
Is This Under-the-Radar Growth Stock a Buy?
10:23am, Thursday, 19'th Jan 2023
This company is a small player in the steadily growing medtech industry.
AngioDynamics (ANGO) Surpasses Q2 Earnings and Revenue Estimates
09:47am, Thursday, 05'th Jan 2023
AngioDynamics (ANGO) delivered earnings and revenue surprises of 200% and 1.65%, respectively, for the quarter ended November 2022. Do the numbers hold clues to what lies ahead for the stock?
Wall Street Thinks This Obscure Growth Stock Could Soar 92% in 2023
10:15am, Friday, 30'th Dec 2022
As COVID-19 headwinds fade, AngioDynamics' business could rebound.
AngioDynamics to Report Fiscal 2023 Second Quarter Financial Results on January 5, 2023
04:01pm, Thursday, 15'th Dec 2022
LATHAM, N.Y.--( BUSINESS WIRE )--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, expa
AngioDynamics to Present at the Piper Sandler Healthcare Conference
04:01pm, Thursday, 17'th Nov 2022
LATHAM, N.Y.--( BUSINESS WIRE )--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, expa
Here's Why This Hidden Growth Stock Is a Buy
09:20am, Friday, 21'st Oct 2022
This medical device company may not be a household name, but it could be an up-and-comer.
4 Toxic Stocks That May Stress You Out Amid Market Turmoil
10:32am, Thursday, 13'th Oct 2022
Just like identifying promising stocks, detecting toxic stocks and dumping them at the right time are crucial to safeguarding one's portfolio from big losses.
AngioDynamics (ANGO) Q1 Earnings, Revenues Lag Estimates
12:47pm, Monday, 10'th Oct 2022
AngioDynamics (ANGO) registers strong revenue growth in the Med Tech business in first-quarter fiscal 2023.
AngioDynamics, Inc.'s (ANGO) Q1 2023 Earnings Call Transcript
01:31pm, Thursday, 06'th Oct 2022
AngioDynamics, Inc. (NASDAQ:ANGO ) Q1 2023 Earnings Conference Call October 6, 2022 8:00 AM ET Company Participants Jim Clemmer - President and CEO Steve Trowbridge - Executive Vice President and CFO
Why AngioDynamics Stock Just Crashed 12%
10:58am, Thursday, 06'th Oct 2022
Is AngioDynamics' earnings miss a buying opportunity?
AngioDynamics (ANGO) Reports Q1 Loss, Misses Revenue Estimates
09:47am, Thursday, 06'th Oct 2022
AngioDynamics (ANGO) delivered earnings and revenue surprises of -200% and 1.99%, respectively, for the quarter ended August 2022. Do the numbers hold clues to what lies ahead for the stock?
AngioDynamics to Report Fiscal 2023 First Quarter Financial Results on October 6, 2022
04:01pm, Thursday, 08'th Sep 2022
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, expand
Here's Why You Should Retain AngioDynamics (ANGO) Stock Now
12:48pm, Wednesday, 31'st Aug 2022
AngioDynamics (ANGO) continues to benefit from strength in segments but forex remains a woe.
